FILE - Comirnaty, a new Pfizer/BioNTech vaccination booster for COVID-19, is displayed at a pharmacy in Orlando, Fla., on Friday, Sept. 15, 2023. Older U.S. adults should roll up their sleeves for another COVID-19 shot, even if they received a booster in the fall, an influential government advisory panel said Wednesday, Feb. 28, 2024. (Joe Burbank/Orlando Sentinel via AP)


February 29, 2024

U.S. health officials recommended on Wednesday that older adults consider receiving another COVID-19 shot, even if they had a booster last fall.

The Centers for Disease Control and Prevention (CDC) advised that individuals aged 65 and above should receive an additional dose of the updated vaccine introduced in September, provided at least four months have elapsed since their last inoculation. This guidance aligns with recommendations proposed by an expert advisory panel earlier in the day.

Dr. Mandy Cohen, Director of the CDC, emphasized the importance of this recommendation, highlighting that most COVID-19-related deaths and hospitalizations last year occurred among individuals aged 65 and older. She underscored that an extra vaccine dose could offer added protection to those at the highest risk.

The decision by the advisory panel followed a thorough debate on whether older individuals "may" or "should" receive the additional shots, reflecting differing expert opinions on the necessity of another booster and concerns about vaccine fatigue among the public. While some doctors argue that most older adults already have sufficient protection from the fall shot, citing immunity from earlier vaccinations and exposure to the virus, preliminary studies show no significant decline in vaccine effectiveness over six months.

However, vaccine-induced immunity tends to diminish over time, especially in seniors, prompting the committee to recommend booster doses for older adults in 2022 and 2023. Despite progress in vaccination efforts, COVID-19 remains a significant threat, particularly to older individuals and those with underlying health conditions, with over 20,000 hospitalizations and 2,000 deaths attributed to the virus each week.

Members of the advisory panel advocating for a "should" recommendation aimed to encourage healthcare providers to offer the shots more emphatically. Dr. Jamie Loehr, a committee member, emphasized the importance of facilitating providers' ability to recommend the additional dose to patients.

In September, the government recommended a new COVID-19 shot targeting the XBB.1.5 variant. While the CDC endorsed these shots for individuals aged 6 months and older, those with weakened immune systems could receive a second dose as early as two months after the initial one. However, vaccine uptake has been modest, with only 13% of U.S. children and approximately 22% of adults vaccinated. Older adults have a higher vaccination rate, nearing 42%.

Dr. David Canaday, an infectious diseases expert, cautioned against over-recommending vaccines, acknowledging vaccine fatigue among the population. Yet, there remains a subset of Americans, particularly those at higher risk, who are seeking guidance on additional doses.

CDC data suggests that individuals who received the latest vaccine are 50% less likely to become ill after exposure to the virus compared to those who did not receive the fall shot, indicating the vaccine's effectiveness in reducing illness.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

You may also like

Fuel Oil Spill Triggers Water Advisory in Minden Hills

A fuel oil spill in Minden Hills has prompted a drinking water advisory for residents relying on South Lake, after....

New Plant Serum Shows Faster Hair Regrowth Results

A team of scientists has developed a plant-based hair growth serum that has shown promising results in early clinical testing,....

Carfentanil Surge Sparks New U.S. Drug Crisis

A quiet life can unravel in seconds. For 36-year-old Michael Nalewaja, it did just days before Thanksgiving 2025. Living in....

From Plague to COVID: Study Reveals Persistent Inequality

A new study comparing victims of a 17th-century plague outbreak with modern-day COVID-19 cases has uncovered a striking pattern: social....

Cognitive Decline Breakthrough: Scientists Identify Single Protein and Potential Cure

A new study on cognitive decline is offering fresh hope by challenging the long-held belief that brain aging is irreversible.....

Common Antidepressant Shows Promise for Long COVID Fatigue

A widely used and affordable antidepressant may offer relief for one of the most persistent symptoms of long COVID—fatigue—according to....

COVID-19 Cicada Variant BA.3.2 Spreads Globally as Experts Monitor Mutation Risks

A new COVID-19 strain, widely referred to as the “Cicada” variant, is drawing attention as it gradually spreads across multiple....

Medication Costs Hit Black Canadians Harder, Study Finds

A new study has uncovered a troubling gap in Canada’s healthcare system: Black Canadians are significantly more likely to skip....

Meningitis B Vaccine Campaign Gains Urgency After Teen Death and Kent Outbreak

A grieving mother’s call for wider access to the meningitis B vaccine is gaining renewed attention as a recent outbreak....

P.E.I. Health Advocates Urge Ottawa to Act on Alberta’s Bill 11

Health advocates in Prince Edward Island are urging federal action against Alberta’s Bill 11, warning the controversial legislation could reshape....

COVID Still Disrupts Lives Years After Infection

For Mike Hall, life changed dramatically in the summer of 2022. What began as a COVID-19 infection for his wife....

Cancer Advocates Urge Colon Screening to Start at 45 in Canada

The Canadian Cancer Society is calling on provinces and territories to lower the starting age for colorectal cancer screening, citing....